Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
About the Research Project
Program
Award Type
Standard
Award Amount
$85,000
Active Dates
January 01, 2025 - December 31, 2026
Grant ID
CA2025002
Acknowledgement
Goals
Sleep disruptions impact males and females differently in later life and are a known risk factor for Alzheimer’s disease.
Unique and Innovative
We believe that the longitudinal methodologies that we are using that allow us to track whole brain phenotypes using magnetic resonance imaging is extremely novel. Further, sex as a biological variable is typically completely overlooked in the context of preclinical work, thus modelling female-specific risk factors for the disease may provide important knowledge that may allow us to move towards precision medicine approaches.
Foreseeable Benefits
There is an overwhelming need to improve our understanding of female health in the context of neurodegenerative disorders. Understanding how sleep disturbance acts as a risk factor for Alzheimer’s diease and how the impact of this biological phenomenon may impact brain health is critical to developing interventions that may act on this important part of daily life.
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
Circadian Rhythm Disruption and Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Ashish Sharma, PhD, MPharm
Current Organization
Washington University in St. Louis
Circadian Rhythm Disruption and Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Ashish Sharma, PhD, MPharm
Current Organization
Washington University in St. Louis